![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/00 | (2006.01) |
C07K 16/28 | (2006.01) |
(11) | Number of the document | 1907424 |
(13) | Kind of document | T |
(96) | European patent application number | 06786260.7 |
Date of filing the European patent application | 2006-06-30 | |
(97) | Date of publication of the European application | 2008-04-09 |
(45) | Date of publication and mention of the grant of the patent | 2015-07-29 |
(46) | Date of publication of the claims translation | 2015-10-26 |
(86) | Number | PCT/US2006/026046 |
Date | 2006-06-30 |
(87) | Number | WO 2007/005874 |
Date | 2007-01-11 |
(30) | Number | Date | Country code |
696426 P | 2005-07-01 | US |
(72) |
KORMAN, Alan, J., US
SELBY, Mark, J., US
WANG, Changyu, US
SRINIVASAN, Mohan, US
PASSMORE, David, B., US
HUANG, Haichun, US
CHEN, Haibin, US
|
(73) |
E. R. Squibb & Sons, L.L.C.,
Route 206 & Province Line Road, Princeton, NJ 08540,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Žmogaus monokloniniai antikūnai prieš programuotą mirties ligandą 1 (PD-L1) |
HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1) |
Payment date | Validity (years) | Amount | |
2025-05-22 | 20 | 347.00 EUR |